Publications by authors named "Maxim M Bespalov"

16Publications

Comparison of liquid chromatography-mass spectrometry and direct infusion microchip electrospray ionization mass spectrometry in global metabolomics of cell samples.

Eur J Pharm Sci 2019 Oct 9;138:104991. Epub 2019 Aug 9.

Drug Research Program and Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2019.104991DOI Listing
October 2019

Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism.

Antiviral Res 2017 Mar 31;139:117-128. Epub 2016 Dec 31.

Department of Virology, Medicum, University of Helsinki, Finland; Department of Virology and Immunology, University of Helsinki and Helsinki University Hospital, Finland; Department of Veterinary Biosciences, University of Helsinki, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2016.12.022DOI Listing
March 2017

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Cancer Discov 2013 Dec 20;3(12):1416-29. Epub 2013 Sep 20.

1Institute for Molecular Medicine Finland, FIMM; 2Hematology Research Unit Helsinki, Helsinki University Central Hospital, University of Helsinki, Helsinki; 3Department of Clinical Chemistry and TYKSLAB, Turku University Central Hospital, University of Turku, Turku; 4Department of Internal Medicine, Tampere University Hospital, Tampere, Finland; 5Department of Clinical Science, Hematology Section, University of Bergen; and 6Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0350DOI Listing
December 2013

Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.

Am J Respir Cell Mol Biol 2013 Apr;48(4):448-55

Division of Pulmonary Medicine, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1165/rcmb.2012-0201OCDOI Listing
April 2013

Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin.

J Cell Biol 2011 Jan 3;192(1):153-69. Epub 2011 Jan 3.

Institute of Biotechnology, Viikki Biocenter, and 2 Neuroscience Center, University of Helsinki, Helsinki 00014, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1083/jcb.201009136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019558PMC
January 2011

Persephin signaling through GFRalpha1: the potential for the treatment of Parkinson's disease.

Mol Cell Neurosci 2010 Jul 27;44(3):223-32. Epub 2010 Mar 27.

Institute of Biotechnology, Viikki Biocenter, University of Helsinki, Helsinki, FIN-00014, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcn.2010.03.009DOI Listing
July 2010

Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.

Exp Neurol 2009 Oct 15;219(2):499-506. Epub 2009 Jul 15.

Division of Pharmacology and Toxicology, Faculty of Pharmacy, P.O. Box 56, FIN-00014 University of Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2009.07.002DOI Listing
October 2009

Sensory neurons from N-syndecan-deficient mice are defective in survival.

Neuroreport 2008 Sep;19(14):1397-400

Institute of Biotechnology, PO Box 56, Viikki Biocenter, University of Helsinki, Helsinki FIN-00014, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNR.0b013e32830d1486DOI Listing
September 2008

Novel computational models for predicting dopamine interactions.

Exp Neurol 2008 May 9;211(1):150-71. Epub 2008 Feb 9.

Center for Heterocyclic Compounds, Department of Chemistry, University of Florida, Gainesville, FL 32611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2008.01.018DOI Listing
May 2008

GDNF family receptor complexes are emerging drug targets.

Trends Pharmacol Sci 2007 Feb 10;28(2):68-74. Epub 2007 Jan 10.

Institute of Biotechnology, University of Helsinki, Viikinkaari 9, PO Box 56, FIN-00014 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tips.2006.12.005DOI Listing
February 2007

The first cysteine-rich domain of the receptor GFRalpha1 stabilizes the binding of GDNF.

Biochem J 2005 May;387(Pt 3):817-24

Institute of Biotechnology, Viikinkaari 9, P.O. Box 56, Viikki Biocenter, University of Helsinki, FIN-00014 Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/BJ20041257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1135013PMC
May 2005